Remove 2005 Remove Patients Remove Pharmaceutical products Remove Safety
article thumbnail

Quality by design with a focus on biosimilars

Pharmaceutical Technology

Quality by design (QbD) is a concept introduced into the pharmaceutical regulatory lexicon in 2005. Dr Amiji says that these harmonisation guidelines help industry understand the necessary requirements for developing pharmaceutical products. Following QbD to guarantee a drug product's safety.

article thumbnail

The imperative of fridge-free vaccines

European Pharmaceutical Review

A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient. About 800 million humans are injected with vaccines every year” Most vaccines in use today are relatively cheap to make and are injected into patients with mass‑produced and inexpensive (five-cent) disposable syringes.